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Abstract
Objective—To evaluate the agreement between the current National Healthcare Safety Network 
(NHSN) definition for ventriculitis and others found in the literature among patients with an 
external ventricular drain (EVD).
Design—Retrospective cohort study from January 2009 to December 2014
Setting—Neurology and neurosurgery intensive care unit of a large tertiary care center.
Patients—Patients with an EVD. Patients with an infection prior to EVD placement or a 
permanent ventricular shunt were excluded.
Methods—We reviewed the charts of patients with a positive cerebrospinal fluid (CSF) cultures 
and/or abnormal CSF results while they had an EVD in place and applied various ventriculitis 
definitions.
Results—We identified 48 patients with a total of 52 episodes of ventriculitis (41 CSF culture 
positive episodes and 11 episodes based on abnormal CSF test results) using the NHSN definition. 
The most common organisms causing ventriculitis were Gram positive commensals (79.2%), 
however 45% of these had growth of only one colony on one piece of media. About 60% of the 
ventriculitis episodes by NHSN definition met Honda criteria, about 56% met Gozal criteria and 
23% met Citerio’s definition. Honda vs. Gozal had a moderate agreement (Ƙ=0.528, p< 0.05) 
whereas Honda vs Citerio (Ƙ=0.338, p< 0.05) and Citerio vs Gozal (Ƙ=0.384, p< 0.05) 
comparisons had only fair agreements.
Conclusions—Agreement between published VAI definitions in this cohort was moderate to 
fair. A VAI surveillance definition that better defines contaminants is needed for more 
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homogenous application of surveillance definitions between institutions and better comparison of 
rates.
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Introduction
Ventriculostomy-associated infection (VAI) is one of the most serious complications of 
external ventricular drain (EVD) use. These infections can result in increased morbidity, 
mortality, prolonged hospital stay and higher healthcare costs.1,2
The reported incidence of VAI varies from under 1% to 45%.1,3 This wide variability in the 
VAI incidence may be in part due to the challenge of diagnosing VAI in the presence of an 
abnormal cerebrospinal fluid (CSF) profile from underlying central nervous system disease, 
recent surgery1,4 and differences between VAI definitions.5,1
The Center for Disease Control and Prevention (CDC) National Healthcare Safety Network 
(NHSN) has a definition for ventriculitis.6 A single positive CSF culture or non-culture 
based microbiological test meets the NSHN ventriculitis definition. Since CSF samples for 
culture are generally drawn through the EVD in the course of routine care, intraluminal 
colonization of the device may result in a positive culture1 thereby meeting the NHSN 
definition.
A recent study by Lewis et al compared the performance of multiple VAI definitions.3 The 
NHSN definition was not included in the comparison and the antibiotic length of therapy 
was used as the gold standard for ventriculitis, which may have introduced bias due to 
variations in antibiotic prescribing practices.7
NHSN surveillance data is increasingly being linked to hospital reimbursement by 
regulatory agencies and payers, such as the Centers for Medicare and Medicaid Services, 
thus understanding the performance characteristics of NHSN definitions is important. The 
objective of our study is to compare VAIs rates using the NHSN definition versus other 
published definitions.
Methods
Study cohort
We conducted a retrospective study of patients who underwent placement of a ventricular 
drain (EVD) between January 2009 and December 2014 and housed in the Barnes-Jewish 
Hospital neurological and neurosurgical intensive care unit.
Inclusion and exclusion criteria
A total of 965 EVDs were identified during the study period. We excluded EVDs placed in 
patients < 18 years old and those who had a permanent shunt, a cerebral abscess, and/or a 
positive CSF culture at time of EVD insertion. From the remaining EVDs, we selected only 
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those EVDs which satisfied the NHSN definition for ventriculitis.6 These included patients 
having a positive CSF culture while the EVD was in place or an abnormal CSF analysis 
result or positive blood cultures in the presence of neurological symptoms. We considered 
only tests that were performed while EVD was in place and up to two days after removal.
NHSN CSF culture-positive episodes
We selected all patients with a positive CSF culture. If multiple organisms grew from a 
single CSF culture, we considered this a polymicrobial episode. If a patient had multiple 
CSF cultures that grew the same organism, we considered it to be a single episode with the 
date of initial positive culture as the episode date. If a patient had multiple CSF cultures 
performed and different organisms grew from more than one culture we considered each 
culture as a different episode. Cultures drawn on the same day or within one calendar day 
were part of the inclusion criteria unless they had a pre-existing infection.
NHSN CSF culture-negative episodes
Patients with at least one CSF glucose measurement <50mg/dl were selected. Patients with 
all of the additional three criteria: CSF protein > 50mg/dl, CSF nucleated cells > 5 
cells/mm3 and fever >38°C, were included for further review.
CSF analysis data (protein, nucleated cells, glucose) obtained contemporaneously with CSF 
culture were considered. If no CSF analysis was obtained when the culture specimen was 
obtained, we then considered the temporally closest CSF analysis performed to the CSF 
culture while the EVD was in place.
If patients did not meet either the positive CSF culture or the abnormal CSF criteria, we then 
conducted a chart review of all patients with a positive blood culture(s) while the EVD was 
in place. If there was suspicion for a central nervous system infectious source, then they 
were included for further evaluation.
Other definitions
We applied three other published VAI definitions (Honda, Gozal and Citerio) to our cohort 
(Table 1)6,8–10. All of these definitions required growth of an organism from CSF culture; 
therefore, all patients who met these definitions were a subset of the patients who met the 
NHSN VAI definition by virtue of a positive CSF culture.
Data collection
Patient demographics, CSF testing, culture and blood culture data was abstracted from the 
hospital medical informatics database. We collected the following data from the charts: date 
of EVD insertion and removal (extracted from the per shift nursing assessment), EVD 
indication for placement, clinical information (maximal temperature, new meningeal or 
cranial nerve signs within 72 hours of CSF testing), and systemic antibiotic therapy while 
EVD was in placed was recorded.
We defined treatment as receiving an antibiotic with activity against the organism(s) 
detected in CSF cultures, based upon susceptibilities. In the case of common commensals 
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with no susceptibilities reported, agents with activity against methicillin-resistant bacteria 
were considered to be active. We defined ≥14 days to be an appropriate length of antibiotic 
therapy for ventriculitis. Of note, prior to May 2012 all EVD patients in our study received 
either cefazolin or vancomycin prior to EVD placement and then as long as catheter 
remained in place. After May 2012 patients received only peri-procedural antibiotics.
Statistical analysis
SPSS version 22 (IBM; Armonk, NY) was used for analysis. Percentage agreement of the 
Honda, Gozal and Citerio definitions with NHSH definition was calculated. The unweighted 
Kappa statistic was used to assess the agreement between Honda, Gozal and Citerio 
definitions.
This study was approved by the Washington University Human Research Protection Office.
Results
After exclusions, our cohort included 49 EVDs (from 48 patients) with 52 episodes of 
ventriculitis, which included 41 culture-positive and 11 culture-negative episodes (Figure 1). 
The median age of the patients was 54 years (interquartile range (IQR) 47–64 years) and 
58.3% were female (n=28). EVD characteristics are described in Table 2.
CSF culture-positive episodes
Thirty-seven patients with 38 EVDs contributed to 41 CSF culture-positive episodes. The 
median time from EVD insertion to first positive culture was 8 days (IQR 4–12 days). Two 
of the 41 CSF culture-positive samples were not sent for CSF analysis. The median number 
of nucleated cells in the remaining 39 samples was 60 cells/mm3 (range 0–8440). Thirty 
samples (76.9%) had ≥ 5 nucleated cells/mm3. The median concentration of protein was 
48mg/dl (IQR 27–87); 19 (48.7%) had a protein level > 50mg/dl. The median glucose was 
74mg/dl (IQR 66–90). Only three (7.6%) had a glucose level <50mg/dl.
The microbiology of CSF cultures is shown in Table 3. Of note, 20 (49%) of 41 culture-
positive episodes had an annotation of “one colony on one piece of media” for an organism. 
The organisms growing only a single colony in culture were: coagulase-negative 
Staphylococcus spp (11 cultures), Micrococcus spp (4), Corynebacterium spp (2), Bacillus 
spp, Propionibacterium spp, and unidentified yeast.
Forty (97.6%) positive-culture CSF episodes received some antibiotic therapy. Twenty-two 
(53.6%) received appropriate antibiotic for the organisms cultured. The median length of 
antibiotic use was 5 days (IQR 3–11days). Five patients received treatment for ≥14 days 
(four with Gram negative bacteria; one with Candida parapsilosis). From the 20 cultures that 
had the annotation of “one colony on one piece of media” seven (35%) received an antibiotic 
with activity against the isolated organism; none received antibiotics for ≥14 days.
Among the 38 EVDs with one or more positive CSF cultures, 9 (23.6%) were removed and 
3 (7.9%) were exchanged within 48 hours of the positive culture.
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CSF culture-negative episodes
There were 11 patients with 11 EVDs that contributed to 11 CSF culture-negative episodes 
(Figure 1). The median number of nucleated cells was 375 cells/mm3 (IQR 100–2067). The 
median concentration of protein was 113 mg/dl (IQR 71–332). The median glucose was 45 
mg/dl (IQR 27–48).
All 11 patients received intravenous antibiotics, but none completed 14 days of therapy. Two 
(18%) EVDs were removed within 48 hours of the abnormal CSF test results. The remaining 
9 (81.8%) were neither removed nor exchanged.
Comparison of ventriculitis rates
There were 52 episodes of ventriculitis by NHSN definition: 41 episodes based on a positive 
CSF culture and 11 episodes based upon abnormal CSF test results. Thirty-one of these 
episodes (59.6%), met ventriculitis criteria by the Honda definition, 29 (55.8%) by the Gozal 
definition and 12 (23.1%) by the Citerio definition. The ventriculitis rate varied widely by 
definition (6.7, 4.0, 3.7 and 1.5 per 1000 EVD-days for NHSN, Honda, Gozal and Citerio, 
respectively). No episodes were identified by other three definitions, but not identified by 
NHSN.
Comparing the agreement between the definitions, we found the Honda and Gozal 
definitions had a moderate agreement (Ƙ=0.528, p< 0.05). The other comparisons had only 
fair agreements: Honda vs Citerio (Ƙ=0.338, p< 0.05) and Citerio vs Gozal (Ƙ=0.384, p< 
0.05).
Discussion
Ventriculitis rates in our study varied widely by the definition applied. Compared to three 
culture-based definitions in the literature, the NSHN definition resulted in substantially more 
episodes of VAI being identified. This is most likely due to the NHSN definition defining 
any growth on CSF culture, no matter the organism, the number of abnormal CSF cultures or 
the degree of growth on media as infection. This definition also classified episodes as VAI 
based upon CSF abnormalities plus neurological symptoms, irrespective of culture findings.
In our study, Gram positive commensals were the predominant organisms recovered from 
the CSF cultures (79.3%). These organisms are the most commonly implicated as a cause of 
VAIs,5,1 but also are a frequent cause of culture contamination or catheter colonization. We 
found that 45% of the common commensals had an annotation by the laboratory of “one 
colony on one piece of media”; calling into question their significance as a pathogen. Of the 
other VAIs definitions available in the literature3,9,1 only one used quantification of colony 
forming units and none required more than one positive culture.3 Therefore, most definitions 
may identify either catheter colonization or contamination during collection as a VAI.
The NHSN definition also includes the presence of new cranial nerve signs, meningeal signs 
or headache. Given their underlying pathology, the neurosurgical patients may have these 
signs and symptoms, regardless of infection. Other infection surveillance definitions relying 
on clinical signs and symptoms have been reported to miss cases. A study examining chart-
Reyes et al. Page 5
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
documented signs and symptoms of catheter associated urinary tract infections found that 
only 9.5% of cases had documented dysuria, frequency or urgency and 4.1% had suprapubic 
tenderness or costovertebral angle pain.11 In our cohort, we found only 9 (17.3%) patients 
with new or worsening cranial nerve signs and none for new or worsening meningeal signs.
A surveillance definition that cannot adequately discern VAIs from culture contamination 
may lead to a misinterpretation of clinical practice patterns. In our cohort, only 53.6% of 
NHSN-defined VAI cases received organism-specific antibiotic therapy, and only five 
patients received treatment for ≥14 days. Among “one colony on one piece of media” 
episodes, we found a significantly lower proportion of associated CSF protein > 50mg/dl 
and CSF glucose <50mg/dl versus other episodes (data not shown). Among the NSHN-
defined VAI cases that grew one colony on one piece of culture media, only 35% received 
organism-specific antibiotic therapy, and in all these cases, treatment was <9 days. 
Analogous to central line-associated bloodstream infections, EVD removal is recommended 
in VAI.12 However, among the EVDs in our cohort with a positive CSF culture, 9 (23.6%) 
were removed and 3 (7.8%) exchanged. Among VAIs with negative CSF cultures, only 2 
(18%) EVDs were removed and none exchanged.
Our VAI rate varied considerably, depending on the definition applied. For instance, using 
the Citerio definition,10 there were no cases of VAI in 2012; however, using the NHSN 
definition, there were 12 VAI cases, a rate of 10.7 infections per 1000 EVD-days. If trying to 
compare rates between hospitals, this variability becomes problematic.5 Currently, U.S. 
hospitals are mandated to report certain hospital-acquired infections as for quality of care 
metrics which are linked to reimbursement.13 Therefore, it is increasingly important that 
surveillance definitions are reproducible and align well with clinical definitions. We call for 
refining the NHSN VAI definition, adopting a definition similar to the current NHSN central 
line-associated bloodstream infection definition.9 This would increase definition specificity, 
and by removing subjective clinical criteria, allow for automated surveillance.14
The limitations of our study include being retrospective, relying on pre-existing 
documentation, and occurring in single center. We calculated the Cohen’s kappa coefficient 
between the three published definitions, but we could not directly compare them to the 
NHSN definition, since the ventriculitis episodes in all three definitions were a subset of 
NHSN-defined VAI episodes. The strengths of our study include having a large number of 
EVDs placed in our institution and a high number of CSF cultures to allow for comparison 
of various ventriculitis definitions.
The current NHSN ventriculitis definition has limitations that make difficult its use for 
surveillance and to compare VAI rates among institutions. Our data suggest that a 
modification to the current NHSN definition is needed, if such comparisons are to be made 
in the future.
Acknowledgments
Funding for this project was provided in part by the Centers for Disease Control and Prevention Epicenters Program 
(U54CK000162). The findings and conclusions in this document are those of the authors who are responsible for its 
content and do not necessarily represent the official view of the Centers for Disease Control and Prevention. We 
Reyes et al. Page 6
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
thank the Barnes-Jewish Hospital Neurology and Neurosurgical Intensive Care Unit and Infection Prevention staff 
for providing data for this study.
References
1. Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated 
cerebrospinal fluid infections. BMC Infect Dis. 2015; 15:1–12. [PubMed: 25567701] 
2. Gutierrez-Gonzalez R, Boto GR, Perez-Zamarron A. Cerebrospinal fluid diversion devices and 
infection. A comprehensive review. Eur J Clin Microbiol Infect Dis. 2012; 31:889–897. [PubMed: 
21960033] 
3. Lewis A, Wahlster S, Karinja S, Czeisler BM, Kimberly WT, Lord AS. Ventriculostomy-related 
infections: The performance of different definitions for diagnosing infection. Br J Neurosurg. 2016; 
30:49–56. [PubMed: 26372297] 
4. Schade RP, Schinkel J, Roelandse FW, et al. Lack of value of routine analysis of cerebrospinal fluid 
for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg. 2006; 
104:101–108. [PubMed: 16509153] 
5. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a 
critical review of the literature. Neurosurgery. 2002; 51:170–181. discussion 181–172. [PubMed: 
12182415] 
6. Centers for Disease Control and Prevention (CDC). CDC/NHSN Surveillance Definitions for 
Specific Types of Infections. 2015. http://www.cdc.gov/nhsn/PDFs/pscManual/
17pscNosInfDef_current.pdf2015
7. Singh N, Yu VL. Rational empiric antibiotic prescription in the ICU. Chest. 2000; 117:1496–1499. 
[PubMed: 10807841] 
8. Honda H, Jones JC, Craighead MC, Diringer MN, Dacey RG, Warren DK. Reducing the incidence 
of intraventricular catheter-related ventriculitis in the neurology-neurosurgical intensive care unit at 
a tertiary care center in St Louis, Missouri: an 8-year follow-up study. Infect Control Hosp 
Epidemiol. 2010; 31:1078–1081. [PubMed: 20731597] 
9. Gozal YM, Farley CW, Hanseman DJ, et al. Ventriculostomy-associated infection: a new, 
standardized reporting definition and institutional experience. Neurocrit Care. 2014; 21:147–151. 
[PubMed: 24343563] 
10. Citerio G, Signorini L, Bronco A, Vargiolu A, Rota M, Latronico N. External Ventricular and 
Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study. Crit 
Care Med. 2015:1630–1637. [PubMed: 25867904] 
11. Meddings J, Reichert H, McMahon LF Jr. Challenges and proposed improvements for reviewing 
symptoms and catheter use to identify National Healthcare Safety Network catheter-associated 
urinary tract infections. Am J Infect Control. 2014; 42:S236–241. [PubMed: 25239716] 
12. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and 
management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases 
Society of America. Clin Infect Dis. 2009; 49:1–45. [PubMed: 19489710] 
13. (CDC) CfDCaP. Adherence to the Centers for Disease Control and Prevention ’s (CDC’s) Infection 
Definitions and Criteria is Needed to Ensure Accuracy, Completeness, and Comparability of 
Infection Information. 2015. http://www.cdc.gov/nhsn/cms/cms-reporting.html. Accessed May 1st, 
2016
14. Woeltje KF, Lin MY, Klompas M, Wright MO, Zuccotti G, Trick WE. Data requirements for 
electronic surveillance of healthcare-associated infections. Infect Control Hosp Epidemiol. 2014; 
35:1083–1091. [PubMed: 25111915] 
Reyes et al. Page 7
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Inclusion of patients in the study
EVDs: External ventricular drains, EMR: Electronic Medical Record, CSF: cerebrospinal 
fluid. CNS: Central Nervous System. BSI: bloodstream infections. VP: ventriculoperitoneal.
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Table 2
Characteristics of External Ventricular drains (EVDs) in study population.
Variable EVDs (%) (n=49) *
Indication for EVD placement**
Hydrocephalus 43 (87.8%)
Intracranial bleeding 42 (85.7%)
Intracranial tumor 9 (18.4%)
Trauma 3 (6.1%)
Where was the EVD placed?
Neuro intensive care unit 28 (57.1%)
Operating room 13 (26.5%)
Outside hospital 5 (10.2%)
Emergency department 3 (6.1%)
Neurosurgical history?
≤ 30 days before EVD placement 8 (16.3 %)
Surgery while EVD was in place 22 (44.9)
EVDs: External Ventricular drains
*
Includes 48 patients. One patient had 2 EVDs during study period.
**
EVDs could be placed for ≥1 indication.
Infect Control Hosp Epidemiol. Author manuscript; available in PMC 2018 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Reyes et al. Page 11
Table 3
Characteristics of CSF positive cultures
Organisms Frequency
(n=54*)
Gram positive bacteria Coagulase negative Staphylococcus spp 24 (44.4%)
Micrococcus spp 6 (11.1%)
Corynebacterium spp 4 (7.4%)
Propionibacterium spp 3 (5.6%)
Streptococcus spp 3 (5.6%)
Bacillus spp 2 (3.7%)
Arthrobacter spp 1 (1.9%)
Gram negative bacteria Enterobacter spp 3 (5.6%)
Neisseria spp 2 (3.7%)
Morraxella spp 1 (1.9%)
Klebsiella spp 1 (1.9%)
Serratia spp 1 (1.9%)
Brenvudimonas spp 1 (1.9%)
Fungal Candida parapsilosis 1 (1.9%)
Unidentified yeast 1 (1.9%)
Note:
*Of 41 episodes. Four cultures were polymicrobial: Two had 2 organisms, one had 4 and another one had 9 organisms from a single culture.
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